Hanlin Li
Hanlin Li is associate director at Vertex Pharmaceuticals.
Articles
Risk-Based Predictive Stability for Pharmaceutical Development–A Proposed Regulatory Template
Jin Wang;Fenghe Qiu;Megan McMahon;Elke Debie;Helen Williams;Dennis Stephens;Cherokee Hoaglund Hyzer;Yan Wu;Hanlin Li
August 2nd 2018A published regulatory template sharing best practices for filing RBPS data would benefit the industry and regulatory reviewers by enabling a consistent presentation of predictive data and conclusions.
Latest Updated Articles
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: November 6th 2024 | Updated: November 20th 2024
Automate Aseptic Filling: Closing the System at Full Modularity
Published: November 5th 2024 | Updated: November 20th 2024
Untethered Data: Unifying and Contextualizing Drug Discovery Data
Published: November 8th 2024 | Updated: November 20th 2024
Application of Validation Principles to the Training Quality System: Part 9, Quality Risk Management Hazard Identification
Published: November 4th 2024 | Updated: November 20th 2024
Strategies for Overcoming Common Challenges in Tech Transfer
